Payment overview · 2025
General Payments
$60.51
3 reported records · 2 companies
Healthcare provider profile · identity verified
Adil M Baig, M.D.
Allopathic & Osteopathic Physicians|Family Medicine|Adult Medicine · YUMA, AZ · NPI 1356724967
Verified facts
What the public records show
CMS Open Payments records show Adil M Baig, M.D. received $60.51 in general payments during 2025 across 3 reported records.
Abbott Laboratories accounted for 76.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $46.54 | 76.9% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $13.97 | 23.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $60.51 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $46.54 | 2 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $13.97 | 1 | 2025 |
Source payment records
|
|||||
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $13.97 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 894 | 279 |
| Levothyroxine Sodium | Levothyroxine Sodium | 672 | 219 |
| Omeprazole | Omeprazole | 501 | 172 |
| Lisinopril | Lisinopril | 465 | 146 |
| Losartan Potassium | Losartan Potassium | 456 | 156 |
| Amlodipine Besylate | Amlodipine Besylate | 454 | 149 |
| Metformin Hcl | Metformin Hcl | 411 | 128 |
| Trazodone Hcl | Trazodone Hcl | 362 | 147 |
| Tamsulosin Hcl | Tamsulosin Hcl | 338 | 116 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 325 | 110 |
| Gabapentin | Gabapentin | 306 | 114 |
| Pantoprazole Sodium | Pantoprazole Sodium | 282 | 92 |
| Simvastatin | Simvastatin | 282 | 87 |
| Metoprolol Succinate | Metoprolol Succinate | 253 | 87 |
| Hydrochlorothiazide | Hydrochlorothiazide | 245 | 79 |
| Metoprolol Tartrate | Metoprolol Tartrate | 214 | 65 |
| Montelukast Sodium | Montelukast Sodium | 198 | 65 |
| Furosemide | Furosemide | 164 | 68 |
| Pravastatin Sodium | Pravastatin Sodium | 155 | 50 |
| Carvedilol | Carvedilol | 141 | 43 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 141 | 46 |
| Allopurinol | Allopurinol | 136 | 41 |
| Fluoxetine Hcl | Fluoxetine Hcl | 133 | 49 |
| Glipizide Er | Glipizide | 130 | 50 |
| Clopidogrel | Clopidogrel Bisulfate | 123 | 48 |
| Sertraline Hcl | Sertraline Hcl | 121 | 40 |
| Eliquis | Apixaban | 119 | 37 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 118 | 37 |
| Potassium Chloride | Potassium Chloride | 118 | 44 |
| Duloxetine Hcl | Duloxetine Hcl | 110 | 36 |
| Atenolol | Atenolol | 106 | 32 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 106 | 42 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 105 | 32 |
| Fluticasone Propionate | Fluticasone Propionate | 101 | 37 |
| Meloxicam | Meloxicam | 101 | 29 |
| Citalopram Hbr | Citalopram Hydrobromide | 94 | 28 |
| Finasteride | Finasteride | 87 | 26 |
| Warfarin Sodium | Warfarin Sodium | 81 | 22 |
| Bupropion Xl | Bupropion Hcl | 80 | 32 |
| Lovastatin | Lovastatin | 80 | 22 |
| Alprazolam | Alprazolam | 76 | 32 |
| Synthroid | Levothyroxine Sodium | 75 | 23 |
| Ezetimibe | Ezetimibe | 65 | 25 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 65 | 24 |
| Zolpidem Tartrate | Zolpidem Tartrate | 64 | 22 |
| Fenofibrate | Fenofibrate | 63 | 21 |
| Spironolactone | Spironolactone | 63 | 19 |
| Celecoxib | Celecoxib | 58 | 24 |
| Famotidine | Famotidine | 57 | 20 |
| Jardiance | Empagliflozin | 57 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 56 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 55 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 53 | 20 |
| Glipizide | Glipizide | 52 | 17 |
| Paroxetine Hcl | Paroxetine Hcl | 52 | 17 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 49 | 16 |
| Estradiol | Estradiol | 49 | 15 |
| Tramadol Hcl | Tramadol Hcl | 48 | 25 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 47 | 14 |
| Metformin Hcl Er | Metformin Hcl | 46 | 14 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 42 | 13 |
| Valsartan | Valsartan | 41 | 16 |
| Lorazepam | Lorazepam | 40 | 12 |
| Ozempic | Semaglutide | 40 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 38 | 33 |
| Sumatriptan Succinate | Sumatriptan Succinate | 36 | suppressed |
| Glimepiride | Glimepiride | 35 | 15 |
| Nifedipine Er | Nifedipine | 35 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 34 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 33 | 14 |
| Topiramate | Topiramate | 33 | suppressed |
| Xarelto | Rivaroxaban | 33 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 32 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 31 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 31 | 11 |
| Verapamil Er | Verapamil Hcl | 31 | suppressed |
| Bumetanide | Bumetanide | 30 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 30 | 28 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 30 | 19 |
| Oxybutynin Chloride | Oxybutynin Chloride | 30 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 29 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 27 | suppressed |
| Nitroglycerin | Nitroglycerin | 27 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 26 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 26 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 26 | suppressed |
| Metronidazole | Metronidazole | 26 | 25 |
| Pregabalin | Pregabalin | 25 | 11 |
| Doxazosin Mesylate | Doxazosin Mesylate | 24 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 24 | suppressed |
| Ibuprofen | Ibuprofen | 24 | suppressed |
| Lansoprazole | Lansoprazole | 24 | suppressed |
| Naproxen | Naproxen | 24 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 23 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | 19 |
| Testosterone Cypionate | Testosterone Cypionate | 23 | suppressed |
| Latanoprost | Latanoprost | 22 | suppressed |
| Methylprednisolone | Methylprednisolone | 22 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 22 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 21 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 21 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | 11 |
| Chlorthalidone | Chlorthalidone | 20 | suppressed |
| Entresto | Sacubitril/Valsartan | 20 | suppressed |
| Mounjaro | Tirzepatide | 20 | suppressed |
| Premarin | Estrogens, Conjugated | 20 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 20 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 19 | suppressed |
| Azithromycin | Azithromycin | 19 | 19 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 19 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 19 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 19 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 19 | suppressed |
| Lamotrigine | Lamotrigine | 18 | suppressed |
| Ramipril | Ramipril | 18 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Irbesartan | Irbesartan | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Levetiracetam | Levetiracetam | 16 | suppressed |
| Myrbetriq | Mirabegron | 16 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Clonazepam | Clonazepam | 14 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 14 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 14 | suppressed |
| Prednisone | Prednisone | 14 | suppressed |
| Sotalol | Sotalol Hcl | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Baclofen | Baclofen | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | 11 |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 13 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Temazepam | Temazepam | 12 | suppressed |
| Digoxin | Digoxin | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Memantine Hcl | Memantine Hcl | 11 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $60.51 · 3 records | Abbott Laboratories | EVENITY, FREESTYLE LIBRE 3, PROLIA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error